Skyward Specialty Insurance Group, Inc. logo

Skyward Specialty Insurance Group, Inc.

SKWD

NASDAQFinancial ServicesInsurance - Property & Casualty

Previous close

$56.89

+$1.03 · +1.84%

Aug 21, 4:00 PM ET

SKWD company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

82

Deep Value

Momentum

73

Gaining

Sentiment

63

Bullish

Risk resilience

70

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Incorporated in 2006 and headquartered in Houston, Texas, Skyward Specialty Insurance Group, Inc. functions as an insurance holding company. The firm specializes in writing commercial property and casualty insurance policies for clients across the United States. Its extensive range of coverages includes general liability, excess liability, professional liability, commercial auto, group accident and health, property, surety, and workers' compensation.

Industry
Insurance - Property & Casualty
Sector
Financial Services
Headquarters
US
CEO
Andrew Scott Robinson
Listed since
Jan 13, 2023
Employees
611

Market position

Day range

Current $56.89

52-week range

Current $56.89

Open
$56.425
Previous close
$55.86
Volume
523.2K
1.04× average
Average volume
504.9K
Average daily volume
Market cap
2.31B USD
Beta
0.33
Market reference 1
50-day average
$58.2992
-2.42% below average
200-day average
$49.3461
+15.29% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.02B USD
P/E (TTM)
12.87×
P/B (TTM)
1.82×
P/S (TTM)
1.41×
EV / EBITDA
8.86×
Earnings yield
8.23%
Free cash flow yield
19.48%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
34.49%
Operating margin
14.68%
Net margin
11.45%
Return on equity
16.84%
Return on assets
3.55%
Return on invested capital
15.05%

Financial health

Debt / equity
0.34×
Current ratio
0.95×
Altman Z-score
1.3
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends48%33%18%2%Gross margin, FY2021: 25.07%Gross margin, FY2022: 26.43%Gross margin, FY2023: 30.34%Gross margin, FY2024: 28.57%Gross margin, FY2025: 44.01%Operating margin, FY2021: 9.02%Operating margin, FY2022: 7.82%Operating margin, FY2023: 12.30%Operating margin, FY2024: 13.31%Operating margin, FY2025: 15.31%Net margin, FY2021: 7.15%Net margin, FY2022: 6.19%Net margin, FY2023: 9.60%Net margin, FY2024: 10.35%Net margin, FY2025: 12.03%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 25.07%. Gross margin FY2022 26.43%. Gross margin FY2023 30.34%. Gross margin FY2024 28.57%. Gross margin FY2025 44.01%. Operating margin FY2021 9.02%. Operating margin FY2022 7.82%. Operating margin FY2023 12.30%. Operating margin FY2024 13.31%. Operating margin FY2025 15.31%. Net margin FY2021 7.15%. Net margin FY2022 6.19%. Net margin FY2023 9.60%. Net margin FY2024 10.35%. Net margin FY2025 12.03%.

Income trends

Revenue

1.41B USD+23.18%

Operating income

216.42M USD+41.70%

Net income

170.03M USD+43.09%
Income trends across reported periods1.55B USD1B USD450.92M USD−99.22M USDRevenue, FY2021: 535.82M USDRevenue, FY2022: 636.41M USDRevenue, FY2023: 895.4M USDRevenue, FY2024: 1.15B USDRevenue, FY2025: 1.41B USDOperating income, FY2021: 48.31M USDOperating income, FY2022: 49.78M USDOperating income, FY2023: 110.1M USDOperating income, FY2024: 152.74M USDOperating income, FY2025: 216.42M USDNet income, FY2021: 38.32M USDNet income, FY2022: 39.4M USDNet income, FY2023: 85.98M USDNet income, FY2024: 118.83M USDNet income, FY2025: 170.03M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 535.82M USD. Revenue FY2022 636.41M USD. Revenue FY2023 895.4M USD. Revenue FY2024 1.15B USD. Revenue FY2025 1.41B USD. Operating income FY2021 48.31M USD. Operating income FY2022 49.78M USD. Operating income FY2023 110.1M USD. Operating income FY2024 152.74M USD. Operating income FY2025 216.42M USD. Net income FY2021 38.32M USD. Net income FY2022 39.4M USD. Net income FY2023 85.98M USD. Net income FY2024 118.83M USD. Net income FY2025 170.03M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue1.41B USD1.15B USD895.4M USD636.41M USD535.82M USD
Cost of goods sold795.02M USD819.78M USD623.75M USD468.21M USD401.47M USD
Gross profit622.11M USD327.89M USD271.65M USD168.2M USD134.35M USD
Operating expenses405.68M USD175.15M USD161.55M USD118.42M USD86.04M USD
Interest expense7.92M USD9.5M USD10.02M USD6.41M USD4.62M USD
Depreciation and amortization3.54M USD3.36M USD3.89M USD4.1M USD5.6M USD
Operating income216.42M USD152.74M USD110.1M USD49.78M USD48.31M USD
Net income170.03M USD118.83M USD85.98M USD39.4M USD38.32M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
91%
10 beats, 1 miss, 0 met estimates
Average EPS surprise
+10.20%
11 comparable reports
Latest EPS result
1.3
Estimate 1.17 · Beat by 11.11%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates1.351.120.890.66Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 25, 2025: actual 0.8, estimate 0.77, surprise +3.90%, Beat. Q2 2025, reported May 1, 2025: actual 0.9, estimate 0.78, surprise +15.38%, Beat. Q3 2025, reported Jul 30, 2025: actual 0.89, estimate 0.86, surprise +3.49%, Beat. Q4 2025, reported Oct 29, 2025: actual 0.71, estimate 0.85, surprise -16.47%, Miss. Q1 2026, reported Feb 23, 2026: actual 1.17, estimate 0.96, surprise +21.87%, Beat. Q2 2026, reported May 6, 2026: actual 1.25, estimate 1.11, surprise +12.61%, Beat. Q3 2026, reported Aug 4, 2026: actual 1.3, estimate 1.17, surprise +11.11%, Beat. Q4 2026, reported Nov 4, 2026: actual —, estimate 1.2, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates789.89M616.1M442.31M268.52MQ1 '25MissQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 25, 2025: actual 304.47M USD, estimate 326.33M USD, surprise -6.70%, Miss. Q2 2025, reported May 1, 2025: actual 330.52M USD, estimate 326.33M USD, surprise +1.28%, Beat. Q3 2025, reported Jul 30, 2025: actual 320.8M USD, estimate 335.28M USD, surprise -4.32%, Miss. Q4 2025, reported Oct 29, 2025: actual 606.51M USD, estimate 453.72M USD, surprise +33.67%, Beat. Q1 2026, reported Feb 23, 2026: actual 439.58M USD, estimate 434.08M USD, surprise +1.27%, Beat. Q2 2026, reported May 6, 2026: actual 667.7M USD, estimate 665.12M USD, surprise +0.39%, Beat. Q3 2026, reported Aug 4, 2026: actual 740.55M USD, estimate 706.59M USD, surprise +4.81%, Beat. Q4 2026, reported Nov 4, 2026: actual —, estimate 753.94M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$66.33

16.59% upside
Past 12 months12-month forecastHigh $72.00Average $66.33Low $59.00

Rating distribution

12 ratings
Strong buy18%
Buy758%
Hold433%
Sell00%
Strong sell00%

Recent analyst actions

12 institutions
TD CowenmaintainHold

SKWD news

SKWD peers

ETFs holding SKWD

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research SKWD

research.disclaimer